This is an outdated version published on 07-03-2026. Read the most recent version.

Development and validation of a high performance liquid chromatographic method determination of Zidovudine encapsulated in PCL nanoparticles

Authors

  • Milena Cristina Ribeiro Souza Magalhães Pharmaceutical and Biotechnological Development at Fundação Ezequiel Dias; School of Pharmacy at Federal University of Minas Gerais
    • Alisson Samuel Portes Caldeira Pharmaceutical and Biotechnological Development at Fundação Ezequiel Dias
      • Hanna de Sousa Rocha Almeida School of Pharmacy at Federal University of Minas Gerais
        • Sílvia Ligório Fialho Pharmaceutical and Biotechnological Development at Fundação Ezequiel Dias
          • Armando da Silva Cunha Junior School of Pharmacy at Federal University of Minas Gerais

            DOI:

            https://doi.org/10.22456/2527-2616.79216

            Keywords:

            zidovudine, nanoparticle, polycaprolactone, HPLC, validation

            Abstract

            A reversed-phase high-performance liquid chromatographic (HPLC) method was developed and validated for the determination of encapsulation efficiency of zidovudine in nanoparticules. The method was carried out in isocratic mode using 0.040M sodium acetate: methanol: acetonitrile: glacial acetic acid (880:100:20:2) as mobile phase, a C8 column at 25ºC and UV detection at 240 nm. The method was linear (r2 ˃ 0.99) over the range of 25.0-150.0 μg/mL, precise (RSD ˂ 5%), accurate (recovery = 100.5%), robust and selective. The validated HPLC-UV method can be successfully applied to determine the rate of zidovudine in nanoparticules.

            Downloads

            Download data is not yet available.

            References

            Piot, P.; Bartos, M.; Ghys, P.D.; Walker N.;

            Schwartlander B. Nature. 2001, 410, 968-

            973.

            Chen, R.Y.; Westfall, A.O.; Raper, J.L.;

            Cloud G.A.; Chatham A.K.; Acosta E.P.; et

            al. AIDS Trd Hum Retroviruses. 2002, 18,

            900-916.

            Chulamokha, L.; DeSimone, J.A.;

            Ponerantz, R.J.; J. Neurovirol. 2005, 11, 76-

            80.

            Fellay, J.; Boubaker, K.; Ledergerber, B.;

            Bernasconi, E.; Furrer, H.; Battegay, M., et

            al. Lancet. 2001, 358, 1322-1327.

            De Souza, M.V.N. Acta Farm. Bonaerense.

            2005, 24, 291-9.

            Perry, C.M.; Faulds, D. Drugs. 1997, 53,

            657-80.

            Lindenberg, M.; Kopp, S.; Dressman, J. B.

            European Journal of Pharmaceutics and

            Biopharmaceutics, 2004, 58, 265–278.

            Dou, H.; Destache, C.J.; Morehead, J.R.;

            Mosley, R.L.; Boska, M.D.; Kingsley, J.; et

            al. Blood. 2006, 108, 2827-2835.

            Shah, L.K; Amiji, M.M. Pharm Res. 2006,

            23, 2638-2645.

            Kaale, E.; Risha, P.; Reich, E.; Layloff, T.P.

            J AOAC Int. 2010, 93(6), 1836-43.

            Ramakanth, R. D.; et al. International

            Journal of PharmTech Research. 2012, 4, 1,

            311-314.

            Alnouti, Y., White, C.A., Bartlett, M.G.

            Biomed Chromatogr. 2004, 18(8), 523-31.

            Pereira, E. A.; Micke, G.A.; Tavares, M. F.

            M. Journal of Chromatography A. 2005,

            1091, 1–2, 169–176

            Kusuma, S. L., et al. International

            journal of research in pharmacy and

            chemistry. 2011, 1,3, 677–680

            Moore, J. D.; Valette, G.; Darque,

            A.; Zhou, X.J.; Sommadossi, J.

            Journal of the American Society for

            Mass Spectrometry. 2000, 11,

            1134–1143

            Estrela, R. de C. E.; Salvadori, M. C.;

            Suarez-Kurtz, G. Rapid Communications in

            Mass Spectrometry. 2004, 18, 10, 1147–

            1155

            The United States Pharmacopeia, 35th ed.

            2012. United States Pharmacopoeial

            Convention: Rockville.

            Fessi, H.; Puiseiux, F.; Devissaguet, J-P.;

            Ammoury, N.; Benita, S. Int. J. Pharm.

            1989, 55, 1.

            International Conference on Harmonisation

            of Technical Requirements for Registration

            of Pharmaceuticals for Human Use;

            Validation of Analytical Procedures: Text

            and Methodology, 2005.

            Souza, S.V.C.; Junqueira, R.G.; Anal.

            Chim. Acta. 2005, 552, 25-35.

            Causon, R.; J Chromatogr B. 1997, 689,

            175-180.

            Santana, F.J.M.; Cesarino, E.J.; Bonato,

            P.S. J Chromatogr B. 2004, 809, 351-356.

            Youden, W.J.; Steiner, E.H. 1975.

            Statistical manual of AOAC - Association

            of Official Analytical Chemistry.

            Washington: AOAC.

            Bedregal, P.; Torres, B.; Ubillús, M.;

            Mendoza, P.; Montoya, E.; J Radioanal

            Nucl Chem. 2008, 278, 801-806.

            Saliba, J.B.; Silva-Cunha A.J.; Gomes,

            E.C.L.; Mansur, H.S.; Da Silva, G.R.;

            Quim. Nova. 2011, 34(1), 140-144.

            Brazil. Agência Nacional de Vigilância

            Sanitária. 2003. Resolução RE n°899 de 29

            de Maio de 2003. Guia para validação de

            métodos analíticos e bioanalíticos, Diário

            Oficial da União: Brasília.

            Downloads

            Published

            28-12-2017 — Updated on 07-03-2026

            Versions

            How to Cite

            Ribeiro Souza Magalhães, M. C., Portes Caldeira, A. S., de Sousa Rocha Almeida, H., Ligório Fialho, S., & da Silva Cunha Junior, A. (2026). Development and validation of a high performance liquid chromatographic method determination of Zidovudine encapsulated in PCL nanoparticles. Drug Analytical Research, 1(2), 1–8. https://doi.org/10.22456/2527-2616.79216 (Original work published December 28, 2017)

            Issue

            Section

            ORIGINAL ARTICLES